Female Directors

Kaitlin Wowak Portrait Hires Feature

Shannon Roddel | April 1, 2020

Medical product recalls number in the thousands each year. In the first quarter of 2018, for example, 84 pharmaceutical companies in the U.S. reported at least one recall. Some 4,500 Food and Drug Administration-approved drugs and devices are pulled from shelves annually — decisions greatly influenced by the presence of women on a firm’s board, according to new research from the University of Notre Dame.

Severe product problems that injure or kill consumers are recalled much faster when there are women on the board, and lower-severity product defects that can be hidden from regulators and not recalled are less often hidden when there are female directors, according to “The Influence of Female Directors on Product Recall Decisions,” forthcoming at Manufacturing & Service Operations Management from lead author Kaitlin Wowak, assistant professor of information technology, analytics and operations in Notre Dame’s Mendoza College of Business.

Read more here. 

 by Daily Domer Staff